Skip to main content
. 2021 Nov 8;89(1):93–103. doi: 10.1007/s00280-021-04358-3

Fig. 2.

Fig. 2

Individual dostarlimab clearance versus body weight on day 1 of cycle 1 for part 1 (A), part 1 plus 2A (B), and intercept and slope data for the populations in A and B